Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

Stellus Capital Investment Corporation (NYSE: SCM) Q4 2024 Earnings Call Transcript March 5, 2025 ...

The latest figures reveal the extent of the club's brush with PSR last June, plus plenty more about their financial position ...

Savaria will host a conference call on Thursday, March 6 th at 8:30 a.m. Eastern Standard Time with financial analysts to discuss results of the period ended December 31, 2024. Investors and members ...

Mayo Clinic set a new record for operating profit last year as the Rochester-based health system continued seeing growth in ...

Rochester, Minn.-based Mayo Clinic reported an operating income of $1.3 billion (6.5% operating margin) in 2024, up from an operating income of $1.1 billion (6% margin) in 2023, according to its March ...

In conjunction with the issuance of its financial results, the Company invites you to listen to its earnings release ...

Pebblebrook is in solid financial shape from a liquidity and a solvency perspective after the merger with LaSalle, but we project that additional asset sales will put the company in great financial ...

Completed $835 Million in Dispositions in 2024, Surpassing High-End of Increased Guidance - Reduced Net Debt by $734 million in 2024; Improved Net Debt to Adjusted EBITDA to 7.6x - Company Meets ...

Record 2024 net revenue of $1.1 billion driving record adjusted operating income, adjusted earnings per share and adjusted free cash flow per shareRecord performance in 2024 underpinned by an 18% ...

Revenue was $384.8 million, up 2.5% from the prior year quarter and core revenue was $386.4 million, up 5.7% from the prior ...